Work

The enzymology of the selective CYP17 lyase inhibitor, VT-464, and its effects in castration-resistant prostate cancer (CRPC) models.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.158

Authors: William R. Moore, Sankar N. Maity, Joel Robert Eisner, Edward P. Garvey, William J. Hoekstra, Mark Anton Titus, Christopher Logothetis, John C. Araujo, Eleni Efstathiou, Robert J. Schotzinger

Institutions: Viamet Pharmaceuticals (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589201393

Cites:

Cited by: 1

Related to: 10